CoChat
Sign Up
Cited by 96Workplace Health and Well-beingMental Health Treatment and AccessEmployment and Welfare Studies

The prevalence and correlates of workplace depression in the national comorbidity survey replication

Open access
Kessler, Ronald C., Merikangas, Kathleen R., Wang, Philip S.·2008·Journal of Occupational & Environmental Medicine
DOI 10.1097/jom.0b013e31816ba9b8PMC PMC2742688
Open this paper in CoChat — free account

Abstract

OBJECTIVE: To review evidence on the workplace prevalence and correlates of major depressive episodes, with a particular focus on the National Comorbidity Survey Replication, the most recent national survey to focus on these issues. METHOD: Nationally representative survey of Diagnostic and Statistical Manual, 4th Revision Mental Disorders. RESULTS: A total of 6.4% of employed National Comorbidity Survey Replication respondents had 12-month major depressive disorder. An additional 1.1% had major depressive episodes due to bipolar disorder or mania-hypomania. Only about half of depressed workers received treatment. Fewer than half of treated workers received care consistent with published treatment guidelines. CONCLUSIONS: Depression disease management programs can have a positive return-on-investment from the employer perspective, but only when they are based on best practices. Given the generally low depression treatment quality documented here, treatment quality guarantees are needed before expanding workplace depression screening, outreach, and treatment programs.

Integrity signals

Registry

Crossref · 10.1097/jom.0b013e31816ba9b8

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two large-scale randomized workplace depression treatment effectiveness trials in the US evaluated cost-effectiveness from an employer perspective and both had positive returns-on-investment to employers; a substantial expansion of worksite depression care management programs occurred in the US after publication.

    “Two separate large-scale randomized workplace depression treatment effectiveness trials have been carried out in the US to evaluate the cost-effectiveness of expanded treatment from an employer perspective.129, 130 Both trials had positive returns-on-investment to employers. A substantial expansion of worksite depression care management programs has occurred in the US subsequent to the publication”

    From The Costs of Depression (2012) · cites this paper as [131]

Cites

Flagged first, then by citations

2 of the 112 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Kessler, R. C., Merikangas, K. R., & Wang, P. S.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Kessler, Ronald C.
ORCID
Venue
Journal of Occupational & Environmental Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2008-04
Volume
50
Issue
4
Pages
381-390
ISSN
1076-2752 (ISSN-L)
DOI
10.1097/jom.0b013e31816ba9b8
PMC
PMC2742688
OpenAlex
W1964325032
Cited by
96
References
112
Citations by year
2025: 1 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 9 · 2018: 5 · 2017: 11 · 2016: 4 · 2015: 8 · 2014: 5 · 2013: 9 · 2012: 6
FWCI
12.76
Type
journal article
Language
en
Open access
Locations
  • Journal of Occupational and Environmental Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Robert Wood Johnson Foundation
  • John D. and Catherine T. MacArthur Foundation
  • John W. Alden Trust
  • World Health Organization
  • National Institutes of Health (5r13mh066849-04, 5r01mh069864-04)
  • Substance Abuse and Mental Health Services Administration
  • Johnson and Johnson
  • Pan American Health Organization
  • National Institute of Mental Health (R13-MH-066849, Z01MH002806, R01MH061941, 1R13 MH066849, U01MH060220, R01‐MH069864)
  • National Institute on Drug Abuse (R01DA016558)
Topics
  • Health Sciences › Health Professions › General Health Professions › Workplace Health and Well-being
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Health Sciences › Health Professions › General Health Professions › Employment and Welfare Studies
Keywords
work-related depression, major depressive disorder, prevalence, National Comorbidity Survey Replication, bipolar disorder, depression treatment, treatment quality, treatment guidelines, return on investment
MeSH terms
Adult, Depression, Health Surveys, Humans, Interviews as Topic, Severity of Illness Index, United States, Comorbidity, Workplace

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review